Latest news
Find out more about our work by reading our latest news stories and insight articles.
Media enquiries
Publications
Featured article
18 September 2025
MedAccess working capital facility to help Hemex boost access to sickle cell diagnosis
MedAccess today announced a $2.5 million working capital facility to help diagnostics innovator Hemex Health Inc. in scaling up access to its pioneering Gazelle® platform for sickle cell disease diagnosis. The facility will enable Hemex to scale to meet the growing demand for Gazelle® in India as well as countries…
Read moreFilter stories
26 January 2023 | News
Next-generation mosquito net found to be highly effective in second key study
A second study in Africa has shown a dual insecticide mosquito net to be highly effective at combatting malaria. The…
19 December 2022 | Insight
8 things to know about drug-resistant tuberculosis
Here are eight things to know about drug-resistant TB that are important in helping us bring an end to this…
19 December 2022 | News
Price reduction paves the way for expanded access to highly effective multidrug-resistant tuberculosis treatment
Pretomanid is part of two new TB treatment regimens with high efficacy and shorter treatment durations, recently recommended by the…
8 December 2022 | News
BASF and MedAccess complete shipment of 35 million Interceptor® G2 nets to fight malaria
63 million people in sub-Saharan Africa are being protected by the nets and more children have been able to access…
28 November 2022 | Insight
Five key lessons from our first five years
MedAccess colleagues share five key learnings from our first five years about using innovative finance to increase access to healthcare.…
1 October 2022 | News
Professor Helen Rees appointed MedAccess Board Chair
MedAccess is pleased to announce the appointment of Professor Helen Rees OBE as the new Chair of the Board of…
21 September 2022 | News
MedAccess expects to deploy more than $150 million to support Global Fund’s fight against HIV, TB and malaria
MedAccess CEO Michael Anderson announced the social finance company’s intention at an event hosted in New York ahead of the…
8 September 2022 | News
P. vivax malaria elimination efforts boosted by new agreement to expand access to G6PD testing
MedAccess, PATH, and SD Biosensor today announced a new partnership aimed at advancing progress towards elimination of P. vivax malaria.…
2 August 2022 | Insight
The reality of undiagnosed syphilis for mothers and babies
Nigeria is ramping up the use of a test which can detect both HIV and syphilis simultaneously. But why is…
